Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by Ventura2020on Sep 07, 2023 10:42pm
216 Views
Post# 35625448

TLRY Medmen New York

TLRY Medmen New York

It is always important to immediatelty refute misinformation that appears on a SH board.  Especially the kind that is designed to confuse or deceive investors as you witness daily from a certain poster!
 

Aug 18, 2021

Michael Serruya has been appointed interim CEO and board chair of MedMen Enterprises, the California-based cannabis multistate operator announced Monday.

His appointment marks the company’s third CEO in less than two years.

100 million investment!
 

TLRY enters into agreement with Medmen. 

Aug 17, 2022 

$165 million Investment. 

Coincidence? Don't think so. 

IS and Surruya have a long history. Matter of fact, he sits on the board lol
 

Aug 18, 2022

Multistate cannabis operator Ascend Wellness Holdings called off its tumultuous acquisition of MedMen Enterprises’ New York operation, citing concerns over the state of the company’s assets.

Ascend CEO Abner Kurtin announced the canceled acquisition on a Monday quarterly earnings call, according to Cannabis Business Times.
 

Why?

TLRY, IS and Surruya made sure the above happened. They weren’t going to let the Apple of the Eye, New York Time Square, 5 ave, heartbeat of America… licence go anywhere but in their pocket. 

TLRY Head Quarters in New York City.
I wonder what they would pay for those assets now, the gang below lol
Some people like to think IS is stupid and gets paid too much and I agree but, he knows the game better than most!

In early August, state Supreme Court Judge Kevin Bryant filed an order that would have allowed licensees who met all approvals before Aug. 7, 2023, to open their stores. However, last week the judge reversed the injunction that could have led to a substantial increase in operational cannabis licensing. The decision was made, the judge noted, pending the outcome of a lawsuit filed by service-disabled veterans. As it stands, the most recent decision essentially blocks all legal retail licensing in the Empire State.  

Meanwhile, over the Labor Day weekend, four major medical marijuana retailers in New York sent a letter to Gov. Kathy Hochul urging her to give them licenses to start selling adult-use cannabis while the courts work out the debacle of mounting lawsuits.  

Signed by Matt Darin, CEO of Curaleaf Holdings, Inc. (OTCQX: CURLF), Ben Kovler of Green Thumb Industries (OTCQX: GTBIF), Denis Curran, CEO of Acreage  Holdings (OTCQX: ACRHF) and Brett Novey, CEO of PharmaCann, the letter was strongly worded.

https://www.benzinga.com/amp/content/34332459
<< Previous
Bullboard Posts
Next >>